SPEAKER
Emerging Concepts in Diabetic Peripheral Neuropathy
Eva L. Feldman MD, PhD
Eva L. Feldman MD, PhD, James W. Albers Distinguished University Professor, and the Russell N. DeJong Professor of Neurology at Michigan Medicine is a neurologist and neuroscientist who has devoted her career towards understanding the etiology of neurological disorders and developing new treatments.
Dr. Feldman is Director of the University of Michigan (UM) ALS Center of Excellence and the NeuroNetwork for Emerging Therapies. She is annually listed in Best Doctors in America, and is a Past President of the Peripheral Nerve Society and American Neurological Association (ANA). She is a member of the National Academy of Medicine (NAM) and was recently elected to the NAM Council , the Association of American Physicians, and a Fellow of the AAAS. She was the inaugural Director of the A. Alfred Taubman Medical Research Institute (2007-2017) to support translational research by clinician scientists.
Dr. Feldman has been continuously NIH funded since 1989 and oversees an established lab with 25 exceptional scientists. Her team conducts pioneering studies on the pathogenesis of neuropathy and dementia in metabolic diseases, leveraging in vitro and in vivo models, clinical specimens, and multiple omics-based approaches. Her work is internationally recognized, with >500 published articles, 70 book chapters and >55,000 citations and in H index of 120.
